Insider: Dambkowski Carl Chief Medical Officer - Apogee Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 233,738 | 0 | 233,738 |
| Value | $8,933,466.36 | $0.00 | $8,933,466.36 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/03/2025 | DDS | 2,535 | Direct | COM | $37.82 | $95,873.70 | 233,738 |
| 09/03/2025 | DDS | 190 | Direct | COM | $38.55 | $7,324.50 | 233,548 |
| 08/06/2025 | DDS | 2,725 | Direct | COM | $37.78 | $102,950.50 | 236,273 |
| 07/02/2025 | DDS | 6,409 | Direct | COM | $44.77 | $286,930.93 | 242,679 |
| 07/02/2025 | DDS | 2,935 | Direct | COM | $45.49 | $133,513.15 | 239,744 |
| 07/02/2025 | DDS | 746 | Direct | COM | $46.26 | $34,509.96 | 238,998 |
| 06/04/2025 | DDS | 2,725 | Direct | COM | $36.96 | $100,716.00 | 241,723 |
| 05/07/2025 | DDS | 2,725 | Direct | COM | $35.75 | $97,418.75 | 244,448 |
| 04/02/2025 | DDS | 500 | Direct | COM | $37.03 | $18,515.00 | 248,062 |
| 04/02/2025 | DDS | 2,471 | Direct | COM | $35.56 | $87,868.76 | 248,562 |
| 04/02/2025 | DDS | 889 | Direct | COM | $37.59 | $33,417.51 | 247,173 |
| 03/05/2025 | DDS | 1,590 | Direct | COM | $30.48 | $48,463.20 | 251,033 |
| 02/05/2025 | DDS | 3,520 | Direct | COM | $40.69 | $143,228.80 | 252,623 |
| 01/02/2025 | DDS | 1,499 | Direct | COM | $46.42 | $69,583.58 | 257,934 |
| 01/02/2025 | DDS | 100 | Direct | COM | $47.92 | $4,792.00 | 255,348 |
| 01/02/2025 | DDS | 2,486 | Direct | COM | $47.21 | $117,364.06 | 255,448 |
| 12/11/2024 | DDS | 4,085 | Direct | COM | $48.62 | $198,612.70 | 258,528 |
| 12/11/2024 | DDS | 455 | Direct | COM | $50.00 | $22,750.00 | 258,073 |
| 12/04/2024 | DDS | 6,665 | Direct | COM | $46.07 | $307,056.55 | 260,798 |
| 11/06/2024 | DDS | 1,339 | Direct | COM | $59.96 | $80,286.44 | 267,463 |
| 11/06/2024 | DDS | 5,326 | Direct | COM | $58.91 | $313,754.66 | 268,802 |
| 10/02/2024 | DDS | 5,740 | Direct | COM | $56.16 | $322,358.40 | 275,053 |
| 10/02/2024 | DDS | 925 | Direct | COM | $56.86 | $52,595.50 | 274,128 |
| 09/04/2024 | DDS | 787 | Direct | COM | $48.06 | $37,823.22 | 280,793 |
| 09/04/2024 | DDS | 5,878 | Direct | COM | $47.49 | $279,146.22 | 281,580 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research